|
Market Closed -
Bombay S.E.
13:02:29 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,338.50 INR | +0.23% |
|
+8.15% | +5.31% |
Company Valuation: Dr. Reddy's Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 714,500 | 767,655 | 1,024,969 | 953,168 | 1,044,616 | 1,115,068 | - | - |
| Change | - | 7.44% | 33.52% | -7.01% | 9.59% | 6.74% | - | - |
| Enterprise Value (EV) 1 | 703,980 | 719,330 | 960,383 | 928,633 | 1,011,902 | 1,084,725 | 1,065,812 | 1,039,139 |
| Change | - | 2.18% | 33.51% | -3.31% | 8.97% | 7.2% | -1.74% | -2.5% |
| P/E | 30.4x | 17.1x | 18.4x | 16.9x | 24.4x | 30.4x | 23x | 19.5x |
| PBR | 3.76x | 3.33x | 3.63x | 2.86x | 2.78x | 2.74x | 2.48x | 2.25x |
| PEG | - | 0.2x | 0.8x | 13.12x | -1x | -2.1x | 0.7x | 1.1x |
| Capitalization / Revenue | 3.33x | 3.11x | 3.67x | 2.93x | 3.11x | 3.17x | 2.84x | 2.58x |
| EV / Revenue | 3.28x | 2.92x | 3.44x | 2.85x | 3.01x | 3.09x | 2.71x | 2.4x |
| EV / EBITDA | 13.7x | 11.1x | 12.1x | 10.8x | 15.1x | 17.3x | 13.2x | 11.3x |
| EV / EBIT | 20.5x | 13.8x | 14.8x | 13.4x | 21.8x | 26x | 18.4x | 15.3x |
| EV / FCF | 52.3x | 15.1x | 33.1x | 49.1x | 30.3x | 30.1x | 32.2x | 23.9x |
| FCF Yield | 1.91% | 6.61% | 3.02% | 2.04% | 3.3% | 3.32% | 3.11% | 4.18% |
| Dividend per Share 2 | 6 | 8 | 8 | 8 | 8 | 7.482 | 8.373 | 9.13 |
| Rate of return | 0.7% | 0.87% | 0.65% | 0.7% | 0.64% | 0.56% | 0.63% | 0.68% |
| EPS 2 | 28.34 | 54.18 | 66.92 | 67.78 | 51.42 | 44.01 | 58.3 | 68.79 |
| Distribution rate | 21.2% | 14.8% | 12% | 11.8% | 15.6% | 17% | 14.4% | 13.3% |
| Net sales 1 | 214,391 | 246,697 | 279,164 | 325,535 | 335,933 | 351,282 | 393,171 | 432,374 |
| EBITDA 1 | 51,400 | 64,559 | 79,481 | 86,236 | 67,048 | 62,797 | 80,785 | 92,091 |
| EBIT 1 | 34,277 | 52,057 | 64,781 | 69,178 | 46,443 | 41,656 | 57,771 | 68,088 |
| Net income 1 | 23,568 | 45,073 | 55,779 | 56,544 | 42,850 | 36,517 | 49,155 | 57,715 |
| Net Debt 1 | -10,520 | -48,325 | -64,586 | -24,535 | -32,714 | -30,343 | -49,256 | -75,929 |
| Reference price 2 | 861.08 | 924.30 | 1,231.03 | 1,144.05 | 1,254.65 | 1,338.50 | 1,338.50 | 1,338.50 |
| Nbr of stocks (in thousands) | 829,771 | 830,526 | 832,611 | 833,152 | 832,596 | 833,073 | - | - |
| Announcement Date | 5/19/22 A | 5/10/23 A | 5/7/24 A | 5/9/25 A | 5/12/26 A | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 30.34x | 3.08x | 17.23x | 0.56% | 11.68B | ||
| 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | ||
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | ||
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | ||
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | ||
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | ||
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | ||
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | ||
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | ||
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | ||
| Average | 29.64x | 6.71x | 18.68x | 1.95% | 404.88B | |
| Weighted average by Cap. | 35.27x | 8.38x | 20.63x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DRREDDY Stock
- Valuation Dr. Reddy's Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















